HTG Molecular Diagnostics Inc (HTGM):企業の財務・戦略的SWOT分析

◆英語タイトル:HTG Molecular Diagnostics Inc (HTGM) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDTC245699FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Technology and Communications
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HTG Molecular Diagnostics Inc (HTG) is a provider of instruments, reagents, and services for molecular profiling applications. The company’s products include HTG edge system, HTG edgeseq reveal software and HTG edgeseq immuno-oncology assay. It develops assays and reagent systems that provide quantitative gene expression analysis in formalin-fixed paraffin embedded tissue. HTG also offers autoimmune panel, immuno-oncology assay, dlbcl cell of origin assay, lung fusions assay, miRNA whole transcriptome assay, mouse mRNA tumor response panel, oncology biomarker panel, and precision immuno-oncology panel. The company serves biopharmaceutical companies, academic research centers and molecular testing laboratories. HTG is headquartered in Tucson, Arizona, the US.

HTG Molecular Diagnostics Inc Key Recent Developments

Apr 05,2021: HTG Molecular Diagnostics Reports Preliminary First Quarter 2021 Financial Results
Mar 25,2021: HTG Molecular Diagnostics Reports Full Year 2020 Results
Mar 16,2021: HTG Molecular Diagnostics to Announce Year End 2020 Financial Results and Host Conference Call on Thursday, March 25
Jan 19,2021: HTG announces board of directors transition
Jan 05,2021: HTG Molecular Diagnostics announces certain preliminary 2020 unaudited financial results

This comprehensive SWOT profile of HTG Molecular Diagnostics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of HTG Molecular Diagnostics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

HTG Molecular Diagnostics Inc – Key Information
HTG Molecular Diagnostics Inc – Overview
HTG Molecular Diagnostics Inc – Key Employees
HTG Molecular Diagnostics Inc – Key Employee Biographies
HTG Molecular Diagnostics Inc – Key Operational Heads
HTG Molecular Diagnostics Inc – Major Products and Services
HTG Molecular Diagnostics Inc – History
HTG Molecular Diagnostics Inc – Company Statement
HTG Molecular Diagnostics Inc – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

HTG Molecular Diagnostics Inc – Business Description
HTG Molecular Diagnostics Inc – Corporate Strategy
HTG Molecular Diagnostics Inc – SWOT Analysis
SWOT Analysis – Overview
HTG Molecular Diagnostics Inc – Strengths
HTG Molecular Diagnostics Inc – Weaknesses
HTG Molecular Diagnostics Inc – Opportunities
HTG Molecular Diagnostics Inc – Threats
HTG Molecular Diagnostics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

HTG Molecular Diagnostics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

HTG Molecular Diagnostics Inc, Key Information
HTG Molecular Diagnostics Inc, Key Ratios
HTG Molecular Diagnostics Inc, Share Data
HTG Molecular Diagnostics Inc, Major Products and Services
HTG Molecular Diagnostics Inc, History
HTG Molecular Diagnostics Inc, Key Employees
HTG Molecular Diagnostics Inc, Key Employee Biographies
HTG Molecular Diagnostics Inc, Key Operational Heads
HTG Molecular Diagnostics Inc, Other Locations
HTG Molecular Diagnostics Inc, Subsidiaries

HTG Molecular Diagnostics Inc, Key Competitors
HTG Molecular Diagnostics Inc, SWOT Analysis
HTG Molecular Diagnostics Inc, Ratios based on current share price
HTG Molecular Diagnostics Inc, Annual Ratios
HTG Molecular Diagnostics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[HTG Molecular Diagnostics Inc (HTGM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bellicum Pharmaceuticals Inc (BLCM):企業の財務・戦略的SWOT分析
    Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a clinical stage biopharmaceutical company, which is engaged in developing cellular immunotherapies for the treatment of cancer. The company develops its product candidates through its chemical induction of dimerization technology platforms in the …
  • Curetis NV (CURE):企業の製品パイプライン分析2018
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company provides diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for cartridges, diseases such as implant and tissue inf …
  • Greenleaf Power LLC:電力:M&Aディール及び事業提携情報
    Summary Greenleaf Power LLC (Greenleaf Power) is a provider of renewable energy services in North America. The company acquires and operates base-load biomass plants to generate electricity. It collects residual biomass material from agricultural, construction, demolition, landfill, and timber indus …
  • Keppel Corp Ltd (BN4):石油・ガス:M&Aディール及び事業提携情報
    Summary Keppel Corp Ltd (Keppel) is an investment holding and management company. The Company, through its subsidiaries, carries out operation in the marine, property, infrastructure and telecommunications and transportation businesses. Keppel focuses on offshore oil-rig construction, repair and upg …
  • Faron Pharmaceuticals Oy (FARN):製薬・医療:M&Aディール及び事業提携情報
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that conducts clinical stage drug discovery and development. The company's pipeline products focus on cute organ traumas, vascular damage and cancer immunotherapy. It offers Traumakine, that helps to prevent vascu …
  • ProPhotonix Limited (STKR):企業の財務・戦略的SWOT分析
    ProPhotonix Limited (STKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • H&R GmbH & Co KGaA (2HR):企業の財務・戦略的SWOT分析
    H&R GmbH & Co KGaA (2HR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Amarantus Bioscience Holdings Inc:企業のM&A・事業提携・投資動向
    Amarantus Bioscience Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amarantus Bioscience Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Idemitsu Kosan Co., Ltd.:企業の戦略・SWOT・財務分析
    Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Atkins Ltd:企業の戦略・SWOT・財務情報
    Atkins Ltd - Strategy, SWOT and Corporate Finance Report Summary Atkins Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Olink Proteomics AB:医療機器:M&Aディール及び事業提携情報
    Summary Olink Proteomics AB (Olink) is a biotechnology company that offers products and services for human protein biomarker research. The company provides portfolio of products such as biomarkers, cardiovascular diseases panels, neurological disease panels, inflammation panels and oncology panels. …
  • Mitochon Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mitochon Pharmaceuticals Inc (Mitochon Pharma) is a biotechnology company that develops drugs for neurodegenerative and neuromuscular diseases. The company’s pipeline products include mitochondrial modulators such as MP-101, MP-201 and MP-301. It targets diseases such as batten disease, stro …
  • Farouk Systems, Inc:企業の戦略・SWOT・財務情報
    Farouk Systems, Inc - Strategy, SWOT and Corporate Finance Report Summary Farouk Systems, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • MS&AD Insurance Group Holdings, Inc.:企業のM&A・事業提携・投資動向
    MS&AD Insurance Group Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MS&AD Insurance Group Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Swisscom, Ltd.:企業の戦略・SWOT・財務情報
    Swisscom, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swisscom, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • CardioNet Inc:医療機器:M&Aディール及び事業提携情報
    Summary CardioNet Inc (CardioNet), a subsidiary of BioTelemetry Inc is a medical device company that develops and markets medical telemetry devices for the healthcare sectors. The company provides proprietary technology and system, mobile cardiac outpatient telemetry that is used in the ECG monitori …
  • U.S. Stem Cell Inc (USRM):企業の財務・戦略的SWOT分析
    U.S. Stem Cell Inc (USRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Tupperware Brands Corp (TUP):企業の財務・戦略的SWOT分析
    Tupperware Brands Corp (TUP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Seair Inc:企業の戦略的SWOT分析
    Seair Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Innospec Inc. (IOSP):石油・ガス:M&Aディール及び事業提携情報
    Summary Innospec Inc (Innospec) is a provider of specialty chemicals. It blends, manufactures and supplies fuel additives and other specialty chemicals. Innospec’s product portfolio includes stabilizers, detergents, cold flow improvers, lubricity improvers, corrosion inhibitors, conductivity improve …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆